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Within the health care setting, there exists a delicate balance between causing and 
preventing harm: the risk-benefit ratio. In the case of surgical antibiotic prophylaxis (SAP), 
the risks of adverse drug reactions and microbial resistance must be weighed against the 
benefit of reduced incidence of surgical site infection (SSI).Therefore, addressing the issue 
may lead to cost saving benefits and improved patient outcomes; as well as contribute 
towards responsible antibiotic stewardship. 
SAP entails the prevention of infectious complications by administering an appropriate 
antimicrobial agent prior to exposure to contamination during surgery. Efficacy depends on 
delivery of the antibiotic in sufficient concentrations before contamination of the surgical 
site occurs.(1) Microbial contamination may be endogenous or exogenous in origin. 
Pathogens commonly responsible for SSI include S. aureus, E. coli, Enterococcus spp. and 
coagulase negative staphylococci.(2) 
 As such, the available literature emphasises the benefit of routinely using SAP, amongst 
other strategies, to prevent SSI during non-clean and implant surgery. In this context, 
“compliance” refers to the administration of a drug when indicated; whilst “adherence” is 
defined as correct practice in all aspects, namely: indication (whether to administer or 
withhold SAP); choice of drug (spectrum of antimicrobial activity); dosage; timing of injection; 
re-dosing intervals and appropriate continuation of SAP beyond the perioperative period 
where indicated. However, these terms are often used interchangeably both in the existing 
literature and clinical setting. 
The term SSI encompasses the surgical wound and associated infections occurring within 30 
days after a surgical procedure; or up to a year later in case of an implant. It is classified as 




2. Problem Globally and in South Africa 
To quote the APACHE study group, “Adherence to current recommendations is hard to 
achieve”,(3) yet arguably important, as preventing SSI without adding to the worldwide 
burden of antimicrobial antibiotic resistance is imperative. 
The worldwide incidence of SSI is 2 – 5% with a peak incidence of 20% for colon surgery.(4) 
It is the third most common cause of nosocomial infection and the most common among 
surgical patients,(5) contributing to the burden of disease by increasing duration of 
hospitalisation, morbidity, mortality and consequently cost.  
According to the American College of Surgeons and Surgical Infection Society, SSI incurs the 
highest cost of all nosocomial infections, extending length of stay by 9.7 days on average(4) 
and increasing the risk of mortality by a factor of 2 to 11.(2) 
 
Effective SAP amounts to preventing SSI by administering a drug that targets the microbes 
most likely to contaminate the surgical site, achieving adequate and timeous tissue levels 
and maintaining this for the duration of the surgery; whilst reducing adverse effects and 
microbial resistance by employing the narrowest possible spectrum of antibiotic for the 
shortest possible period (or omitting where appropriate).(1)(2)(6)(7) 
The purpose of SAP guidelines is to establish such sound practices, but in 2018 a prospective 
descriptive study conducted at a South-African Academic hospital demonstrated that 
anaesthetists’ utilisation and knowledge of SAP guidelines were lacking: only 15.6% followed 
any given guideline in their practice and the mean score for knowledge was 56.2%. The study 
involved testing anaesthetists’ knowledge of SAP by employing a self-administered 
questionnaire. The study population consisted of anaesthetic consultants and registrars from 
a university affiliated Anaesthesiology Department in Johannesburg, South Africa.(8)  
Examples of international, national and local guidelines include: the Scottish Intercollegiate 
Guideline Network (SIGN) – Antibiotic Prophylaxis in Surgery;(1) the South Australia Expert 
Advisory Group on Antibiotic Resistance (SAAGAR) – Surgical antibiotic Prophylaxis 
Guideline;(7) the American Society of Health-systems Pharmacists (ASHP) – Clinical practice 
guidelines for antimicrobial prophylaxis in surgery;(9) the South African Society of 
Anaesthesiologists (SASA) – Guidelines for Infection Control in Anaesthesia in South Africa;(6) 
Guidelines for the management of nosocomial infections in South Africa(10) and the National 




From these guidelines emerge six defining aspects of SAP compliance, namely:  
- indication (to administer or withhold)  
- choice/selection (appropriate spectrum of antimicrobial activity) 
- dosage 
- timing 
-  re-dosing and  
- duration (correct continuation/ discontinuation) of SAP.  
 
Several studies, globally and within the African context, have been aimed at determining 
clinician adherence to existing SAP guidelines. However, none of these studies are from South 
Africa. 
A prospective investigation of three paediatric hospitals in Italy found that where SAP was 
indicated, perfect adherence in terms of antibiotic choice, timing and duration was 8%, with 
first dose timing and duration of prophylaxis being the biggest contributors to error. Under-
use when SAP was indicated (81%) and over-use when not (18%) was also noted.(3)  
Similar findings have been reported by numerous investigators. 
A retrospective monocentric study from France again showed that timing of injection (to 
close to surgical incision) was the most common mistake (34.8% non-compliance), with β-
lactam allergy and obesity leading to non-compliance with choice and dose of antibiotic in 
45% and 96% respectively.(12) 
In Australia, analysis of prospectively collected SSI surveillance data from an academic 
hospital demonstrated issues with drug selection, timing and duration of SAP; and an 
increase in extended-spectrum-β-lactamase producing bacteria.(13)  
Conversely, a Northern American observational study concluded that compliance with 
timing, choice and dose of SAP did not lower the incidence of SSI, but diabetes and elevated 
body mass index were implicated in a higher rate of SSI.(14)  
A Brazilian review from 2015 found that appropriate indication of antibiotic prophylaxis 
ranged from 70.3% to 95%; inappropriate indication from 2.3% to 100%; correct timing 
12.73% to 100%; correct choice 22% to 95%; adequate discontinuation 5.8% to 91.4% and 
adequate antibiotic prophylaxis 0.3% to 84.5%.(15) 
Reasons for non-compliance revolve around issues with clinicians’ knowledge, attitude, 
beliefs, team communication and allocation of responsibilities; as well as institutional 
promotion, support and monitoring of SAP.(16) 
A prospective, international, multicentre cohort study by the GlobalSurg Collaborative 
highlights several issues of concern around SAP and SSI: most notably the relatively greater 
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risk of SSI and higher rates of microbial resistance against SAP, compounded by the paucity 
of high quality research emerging from countries with a low Human Development Index (HDI) 
as opposed to those with a middle- or high HDI. It was further demonstrated that patients 
form low HDI countries were more likely to receive pre-operative courses of antibiotics, SAP 
and post-operative antibiotics, yet the rates of SSI and microbial resistance were also higher. 
Organ space infection, a second nosocomial infection, re-intervention and death were also 
more likely in patients with SSI that those without.(17) 
 
3. The Problem in South Africa 
As mentioned, Jocum et al has demonstrated a lack of awareness of SAP guidelines and 
consequently poor knowledge of SAP administration.(8) 
We postulate that a similar problem exists at Groote Schuur Hospital, resulting in erroneous 
SAP practices. Furthermore, there appears to be no other published studies of SAP practices 
in South Africa. This paucity of research poses a major problem and obscures the true extent 
to which faulty SAP practices may be contributing to SSI, adverse drug reactions and microbial 
antibiotic resistance.  
The guideline for the management of nosocomial infection in South Africa emphasises the 
need for infection control, considering the resource restricted environment in which the 
healthcare system operates. With this in view, it is recommended that measures taken to 
curb antimicrobial spread should be combined with effective and deliberately restrictive 
antibiotic usage.(10) 
 
4. Investigation of The Problem 
Whilst international audits of SAP practices abound, to the author’s knowledge, the only 
South African study is the test of anaesthetists’ awareness and knowledge of SAP guidelines 
by Jocum et al.(8) 
According to reviews led by the WHO, developing countries run a much higher risk of SSI 
than high-income countries for equivalent procedures, yet far fewer interventional studies 
emerge from the higher risk group.(18) 
A systematic review of sub-Saharan interventional studies aimed at preventing SSI, reports 
that research may be confounded by inconsistent definitions of SSI and wound 
classification. Nevertheless, it was clearly demonstrated that once-off pre-operative 
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antibiotic prophylaxis decreases the risk of SSI. For example, in Tanzania the introduction of 
a single dose of pre-operative amoxicillin/clavulanate was associated with a reduction in 
risk of SSI from 21.6% to 4%.  On the other hand, avoiding the use of post-operative 
antibiotic “prophylaxis”, was not associated with an increase in SSI or other adverse events. 
In fact, a South African study found that there is no benefit in prescribing a prolonged 
course of cefoxitine (versus placebo) following caesarean section. The reviewers concluded 
that very little research from sub-Saharan Africa has been aimed at reducing the prevalence 
of SSI, but recently some high-quality studies have emerged.(18) 
Unfortunately, the South African national and provincial SAP guidelines are lacking in detail: 
not all surgical procedures are addressed in terms of indication, required spectrum of 
antimicrobial activity, timing of first injection, redosing intervals or duration of SAP. 
Although it is universally recommended that local and institutional microbial patterns must 
be considered when SAP is selected, information regarding these patterns is 
scant.(1)(5)(6)(10)(11)  
Conversely, clinicians may be overwhelmed by a barrage of inconclusive and sometimes 
contradictory evidence gleaned from of international SAP guidelines. For example, the ideal 
time lag from first injection of antibiotic to surgical incision is generally accepted to be 
between 0 and 60 minutes (with the exception of vancomycin and fluoroquinolones which 
require infusion over 2 hours), but some studies recommend a more exact period while 
others show no statistically significant difference in SSI rates with more specific time 
frames.(2)(19) The only consensus regarding timing of SAP appears to be that the time lag 
should not exceed 1 hour;(1)(2) and  administering SAP after incision is of no benefit and 
may even be harmful in terms of predisposing towards SSI and antimicrobial resistance.(1) 
Some procedures require various combinations of topical, oral and parenteral antibiotic 
prophylaxis(2), adding to the confusion. 
Regarding the ideal duration of SAP, post-operative continuation of antibiotic 
administration predisposes towards C. difficile infection(2), but some procedures warrant 
extended SAP for 24 to 48 hours (arthroplasty, implant – and cardiac surgery).(1)(2)(5) 
 
 
5. Management Of The Problem 
Strategies aimed at improving compliance with SAP guidelines include implementing the 
use of personalised surgical antibiotic prophylaxis kits (SAPKs) at a University hospital in 
Nice;(20) educating surgical staff by introducing an antimicrobial stewardship program at 
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acute care hospitals in Egypt;(21) and incorporating standardised computerised order 
entries for perioperative antibiotic prophylaxis at a university hospital in Philadelphia, 
USA.(22) 
In sub-Saharan Africa, cost constraints, minimal staff and limited facilities number among 
the challenges faced by clinicians, but a systematic review of interventions aimed at 
reducing the rate of SSI in this context postulates that improving the use of SAP may reduce 
the risk of SSI and help conserve scarce (antibiotic) resources. It is recommended that 
antibiotic spectrum appropriate to local pathogens must be identified at duly 
administered.(18) 
The American College of Surgeons and Surgical Infection Society estimates that as much as 
60% of SSI can be prevented if evidence-based methods are correctly implemented. This 
entails the stratification of risk factors for SSI into modifiable or non-modifiable intrinsic 
(patient) factors and extrinsic factors; and addressing these risk factors where possible. In 
terms of SAP, this means: 
- Administering prophylactic antibiotics only when indicated (i.e. not for clean surgery). 
- Choice of antibiotic is determined by the procedure and pathogens that will most likely 
cause SSI. 
- SAP must be administered within an hour before surgical incision; or within 2 hours for 
vancomycin and fluoroquinolones, as these drugs are administered by slow infusion. 
- Prophylactic antibiotic dose should be appropriate for weight. 
- Antibiotic redosing should be aimed at maintaining adequate tissue levels based on the 
half-life of the drug and for every 1.5l of blood loss (in an adult). 
- SAP should be discontinued at closure of incision (barring a few exceptions where the 
ideal duration of SAP remains elusive, namely: implant based breast reconstruction, 
arthroplasty and cardiac surgery.(2) 
 
6. Conclusion 
There appears to be a lack of high-quality evidence on SSI and associated antibiotic use.(17) 
Clinicians are further confounded by poor awareness and knowledge of existing SAP 
guidelines.(8) As part of a broader strategy of SSI prevention and antibiotic stewardship, we 
recommend the following: 
- regular auditing of institutional SAP practices.  
- comparison to guidelines. 
-  implementation of SAP awareness campaigns.  
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- clinician education.
- focused antibiotic stewardship programs.
- Implementation fidelity studies and randomised controlled trials to elucidate whether
SAP related interventions curb the rate of SSI.
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The aim of surgical antibiotic prophylaxis (SAP) is to prevent surgical site infection (SSI) by 
administering an appropriate antimicrobial agent perioperatively. However, SAP may be 
associated with adverse effects and incurs added costs.  
Objectives:  
• The primary objective of this prospective study is to establish whether clinicians 
are adhering to existing perioperative antibiotic prophylaxis guidelines in terms 
of indication, dosage and timing of SAP. 
• Secondary objectives are to determine the proportion of patients receiving 
inappropriate antibiotics; and to evaluate correct practice concerning re-dosing 
and duration of SAP. 
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Methods:  
A cross-sectional prospective audit of the anaesthetic records and prescription charts of 
surgical patients was conducted at Groote Schuur Hospital, a tertiary level teaching hospital 
in Cape Town, South Africa, over a period of one week. Data were collected by 
anaesthetists – blinded to the study objectives – and the investigators; then captured on 
Excel spread sheets and compared to existing SAP guidelines. Descriptive statistics and 
binary logistic regression were used for analysis. 
Results:  
Of the 192 patients consented, 180 questionnaires were completed for data analysis. The 
median age of participants was 44.5 years (IQR: 31.5-58), with a preponderance of females 
(58.7%). SAP was administered in 149 cases (82.8%) and withheld in 31 (17.2%). This was 
appropriate in 91.9% (137/149) and 77.4% (24/31) respectively. Twelve patients (6.7%) 
received inappropriate antibiotics and in seven (3.9%) it was inappropriately withheld. Of 
the 156 patients who should have received SAP, choice of drug was correct in 121 (77.6%), 
dosage in 110 (70.5%) and timing in 87 (55.8%). Absolute compliance was achieved in 
44.4% (80/180). Errors were mostly related to timing, re-dosing and duration of SAP. 
Conclusion:  
Anaesthetists and surgeons at Groote Schuur Hospital demonstrate variable adherence to 
surgical antibiotic prophylaxis guidelines. Interventions aimed at improving compliance are 
warranted. 
Keywords:  
Surgical antibiotic prophylaxis, adherence, compliance, guidelines, surgical site infection. 
3. Introduction
Surgical site infection (SSI) is associated with a significant increase in morbidity and 
mortality.(1)(2)(5) The role of surgical antibiotic prophylaxis (SAP) as part of a broader 
strategy of SSI prevention has been well described in the literature.(1)(2)(5)(17)(23) 
However, establishing the exact impact of adherence to SAP guidelines on the incidence of 
SSI has proven to be difficult.(1)  
In South Africa, the paucity of published, comprehensive national and local guidelines may 
contribute towards clinicians’ lack of knowledge, understanding and utilisation of correct 
perioperative antibiotic prophylaxis (PAP). In a prospective, descriptive study of 
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anaesthetists’ knowledge of SAP, only 20% of participants were able to name any 
guidelines. A questionnaire was employed to test the anaesthetists’ knowledge of 
indication for prophylaxis, spectrum of cover, timing of first dose and exceptions, re-dosing 
intervals and duration of SAP for various antibiotics. The mean score was 56.2%. This 
appears to be the only existing study of clinicians’ awareness and utilisation of SAP and SAP 
guidelines in this country.(8) 
While there have been many retrospective and prospective studies published on SAP 
compliance internationally,(3)(12)(14) (24)(25) to the author’s knowledge, none have been 
conducted in South Africa. 
As there appears to be an urgent need for both research and intervention as far as the SAP 
practice of South African clinicians is concerned, the primary objective of this study was to 
establish the compliance with existing SAP guidelines in terms of indication, selection, 
dosage and timing of SAP. Secondary objectives were to determine the proportion of 
patients receiving antibiotics inappropriately; and evaluate re-dosing and duration of SAP. 
In view of the minimal local and national guidelines,(6)(11)(10) we also employed 
international guidelines(1)(5)(7)(23) in our evaluation of clinicians’ adherence to SAP 
guidelines. 
4. Research Methods and Study Design
4.1.1. Study design 
A cross-sectional prospective descriptive research design was used for this facility-based 
study.  
4.1.2. Setting 
The study population consisted of adult patients over eighteen years of age presenting to 
Groote Schuur Hospital for surgery. All surgical subspecialties were included. Recruitment 
took place during one week from 07h00 on Monday until 19h00 on Friday. 
4.1.3. Data collection 
The anaesthetists were tasked with recruiting patients, obtaining their consent and 
recording the following information: date; patient number, age and weight; surgical 
procedure, whether emergency or elective; diagnosis; surgical wound classification†; time 
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of surgical incision; duration of surgery; known allergies and recent prescription of 
antibiotics. The investigator subsequently reviewed the anaesthetic records and 
prescription charts to document information regarding SAP:  whether administered or 
withheld (indication); choice  (selection/ antimicrobial spectrum) and dosages of drugs; 
time of injection; re-dosing (drug, dosage, time) and whether further antibiotics were 
prescribed for twenty-four hours or longer. 
These data were then captured on Excel spreadsheets. 
 Because awareness of observation might give rise to changing practice (Hawthorne effect), 
the anaesthetists assisting with data gathering were not informed of the purpose of the 
study. 
 At Groote Schuur hospital, antibiotics are administered by the anaesthetists 
perioperatively. This is mostly done in conversation with the operating surgeon. Post-
operative antibiotics are usually prescribed by the surgeons. 
4.1.4. Data analysis 
This SAP audit was based on the Scottish Intercollegiate Guidelines Network (SIGN) 
recommendations for a minimum data set*(see supplementary file 1). 
The data were evaluated by an intensivist and specialist medical microbiologist and 
compared to international and national SAP guidelines: SIGN,(1) South Australian expert 
Advisory Group on Antimicrobial Resistance (SAAGAR),(7) American College of Surgeons and 
Surgical Infection Society: Surgical Site Infection Guidelines,(2) South-African Society of 
Anaesthesiologists (SASA),(6) National Health Laboratory Service Western cape academic 
hospitals antimicrobial recommendations (NHLS);(11) and the only (unpublished) local 
guideline made available, from the Groote Schuur Department of Urology. However, the 
SASA and NHLS recommendations lack detail, hence the inclusion of international guidelines. 
According to the European Centre for Disease Control (ECDC), the defining aspects of SAP 
compliance are correct indication; selection; dosage; timing, and duration of antibiotic 
treatment.(23) Redosing was also included. These criteria were analysed as follows: 
 
Indication 
Administration of SAP was considered appropriate for clean-contaminated, contaminated 
and dirty surgeries or where surgical prostheses were implanted, and inappropriate for clean 
surgeries. Omission/ withholding of SAP was considered appropriate for clean surgeries (that 





Spectrum of antimicrobial activity was evaluated by a microbiologist and intensivist from 
Groote Schuur Hospital in consideration of both their knowledge of local patterns of 
microbial sensitivity and recommendations from existing guidelines. 
 
Dosage 
Dosage: as prescribed by guidelines.(1)(6)(7)(9)(11)  
Table 1: Summary of SAP dosages considered correct  
Drug Dosage (Adult only) 
Cefazolin 2g (1g acceptable if weight ≤ 80kg) 
Gentamycin 5 – 7mg/kg 
Metronidazole 500mg 
Clindamycin  600mg 
Amoxycillin/Clavulanic acid 1.2g 
 
Timing 
Timing of initial injection was considered correct if 15 to 60 minutes had elapsed prior to 
surgical incision or tourniquet insufflation for Cefazolin, Metronidazole, Gentamycin, 
Clindamycin, Ampicillin and Amoxycillin/clavulanic acid (fluoroquinolones and glycopeptides 
require infusion over one to two hours).(9)  
 
Re-dosing 
Redosing was considered appropriate if the duration of surgery exceeded two half-lives of 
the given antibiotic; or blood loss exceeded 1.5 l (in an adult).The time lag between the first 
and subsequent injections was considered correct if two half-lives had elapsed (4 hours for 
Cefazolin). The dose should be appropriate for weight or consistent with the initial dose in 
case of unknown or estimated weight. 
 
Duration 
Prolonged SAP for up to 24 hours was deemed correct for arthroplasty and orthopaedic 
implant surgery; and up to 48 hours for cardiac surgery. Allowances were made where 
complicated surgery, intra-operative spillage of bowel content or pre-existing infections 
necessitated antibiotic treatment beyond SAP. 
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Statistical analysis 
Data were entered into a Microsoft excel database and analysed using Stata version 15. 
(Stata Corp). Since most of the variables were categorical, the Fisher’s exact test was used to 
assess associations between the variables, disaggregated by whether SAP was withheld or 
given. For the continuous variables the comparison between those who received SAP and 
those who had it withheld, was via Mann-Whitney U test, as the variables were skewed. A p-
value of <0.05 was considered statistically significant. 
4.1.5. Ethical considerations 
Ethical approval was obtained from the Human Resources Ethics Committee (HREC) of the 
University of Cape Town, South-Africa (HREC 757/2017). 
5. Results
Over a 1-week period, 194 patients were approached and 192 granted consent. Their 
anaesthetic records and prescription charts were reviewed, and these data were captured 
on data sheets. Of these, 180 were included for data analysis, as 12 sheets were 
unintelligible.  
The median age of study participants was 44.5 years (IQR: 31.5-58), with a preponderance 
of females at 57.8%. The median estimated weight was 74kg (IQR: 61-90). 
Most patients presented for elective surgery (79.4%, 143/180) with the highest proportion 
of procedures coming from the Orthopaedic department (20.6%, 37/80). The surgical 
characteristics are summarised in Table 2. 
Table 2: Descriptive data for baseline surgical characteristics for the study sample (n = 180) 


























































A total of 28 patients had been receiving antibiotic treatment prior to presenting for 
surgery, as summarised in Table 3. 
 
Table 3: Antibiotic treatment prior to surgery (n=180) 
Prior antibiotics  
None  
Ofloxacin 
Azithromycin and Ceftriaxone 
Cefazolin  
Ceftriaxone  
Ciprofloxacin and Cefuroxime 











Ertapenem and imipenem 
Metronidazole  
Nitrofurantoin 
Amikan, Piptaz and Ciprofloxacin 







The various choices/ combinations for SAP are illustrated in Table 4. 
Table 4: SAP drug choice (n=180) 
Antibiotic prophylaxis 
Cefazolin 
Cefazolin, Gentamycin and Metronidazole 
Cefazolin and Amoxycillin/Clavulanic acid 
Cefazolin and Gentamycin 



















In terms of the primary objectives: 
Indication and Selection 
SAP was appropriately administered or withheld in 161 cases (89.44%). Of the 149 patients 
who received SAP, it was appropriately administered in 137 cases (92%) and appropriately 
withheld in 24 of the 31cases that did not (77%). Consequently, SAP was incorrectly 
administered in 12 (clean) cases (12/180 = 6.67%) and incorrectly withheld in 7 (7/180 = 
3.89%). An appropriate antibiotic was selected in 121/156 cases (77.6%).  
Dose 
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The dose was appropriate to weight in 110 of the 156 patients who received SAP (70.5%). 
There was consistent under-dosing of Gentamycin. 
Timing 
Timing of initial injection was incorrect in 44.2% of the 156 participants that received SAP (n 
= 69), the time lag being too short (< 15min) in 33 cases (21.2%); too long ( > 60min) in 13 
(8.3%); unknown in 9 (5.8%) and administered after surgical incision in 7 cases (4.5%) . 
Regarding secondary objectives: 
Re-dosing 
Sixteen cases required a second dose of SAP, but it was administered only 14. Of these 14, 
only 3 (21.4%) received an appropriate dose at an appropriate time. Under-dosing for 
weight occurred in 6 cases (42.9%), re-dosing too late in 3 (21.4%) and too early in 2 
(14.3%). The second dose was incorrectly omitted in 2/16 cases (12.5%). 
Duration 
Antibiotics were prescribed for 24 hours in 57 cases (31.7%) but justified in only 41 (71.9%); 
and for 48 hours or more in 38 cases (21.1%). Extended duration was appropriate in 33 
(86.8%) of these cases, as they were on antibiotic treatment for previously existing or 
suspected infection. SAP was inappropriately extended for 72 hours in 2 cardiac cases 
(5.3%) and 48 hours for 2 orthopaedic cases (5.3%) respectively. One obstetric patient 
received oral amoxycillin/clavulanic acid for 1 week, as this was thought to be warranted 
should the duration of a caesarian section exceed 1 hour, but this practice is not supported 
by the literature. Maxillofacial cases were correctly prescribed an extended course of oral 
or topical antibiotic, as per the WHO recommendations. 
These findings are summarised in Table 5. 
Table 5: Rate of adherence in terms of antibiotic choice, dose, timing and re-dosing. 
Characteristic Total (n=180) 






























Adherence to all the criteria of SAP compliance was achieved in 44.4% (n = 80). 
Breakdown by department is shown in figure 1. 
Figure 1: Percentage of cases where adherence to SAP guidelines was achieved in all 































(HNB: head, neck, breast; ENT: ear, nose, throat; Uro: Urology; OBGYN: obstetrics and 
gynaecology; General: colorectal-, hepatobiliary-, and upper gastro-intestinal surgery) 
Erroneous omissions appear to be due to clinicians’ assumption that previously prescribed 
antibiotics negate the need for SAP, regardless of the spectrum or half-life of those drugs. 
The reasons for incorrect timing may vary from logistical issues (many activities being 
performed at the same time around induction of anaesthesia and surgical incision) to lack 
of awareness of guidelines and inconsistencies in the available literature. While there is 
agreement in the literature that adequate tissue levels of the antibiotic must be attained 
prior to surgical incision or tourniquet insufflation, the ideal time lag has not been 
elucidated.(1)For example, the Belgian recommendation is 15 to 60 minutes,(12) but the 
SIGN recommends 0 to 60 minutes, (1) and the WHO safety checklist reads, “antibiotic 
administered within 30 to 60 minutes prior to surgical incision”. There is low quality 
evidence that administering SAP after surgical incision is harmful with a significantly 
increased risk of SSI, but due to the severity of  morbidity associated with SSI, the 
recommendation against such a dosing strategy is strong.(1) (5)  
The under dosing of Gentamycin may be due to anaesthetists being unfamiliar with the 
antibiotic, as it is prescribed less often and mostly for surgeries involving the urinary tract. 
Concerning duration of SAP, there appears to be consensus amongst the sources quoted by 
the WHO that SAP should not exceed a single pre-operative dose, with the possible 
exceptions of arthroplasty, open cardiac surgery and complicated maxillofacial surgery. The 
Royal College of Physicians of Ireland recommends prolonged SAP for up to 24 hours for 
open reduction and internal fixation of compound mandibular fractures, orthognathic 
surgery, complicated septorhinoplasty and head and neck surgery; and 24 to 48 hours for 
open cardiac surgery. According to the USA Institute for Health Care Improvement: surgical 
site infection, SAP must be discontinued within 24 hours or 48 hours for cardiac 
patients.(5).  
6.1.1. Strengths and limitations:  
The main strength of this study lies with its prospective nature, as opposed to the 
retrospective data analysis described in many of the larger studies. It appears to be the first 
24 
audit of SAP practice undertaken in South-Africa; and as such highlights many shortcomings 
in this arena. 
Limitations to this study include a small sample size, which prohibits generalisation and may 
impact on the reported results. For example, the impact of drug allergies on SAP compliance 
could not be elucidated, as none of the participants had a history of β-lactam allergy. 
Convenience sampling may also have led to selection bias. Furthermore, only some aspects 
of the data were directly observed and recorded by the anaesthetists, but to avoid the 
Hawthorne effect, information directly pertaining to the primary and secondary objectives 
were obtained from paper records in patient folders – which may have contained inaccurate 
information. The weight was known in only 83 (46.1%) and estimated in 97 (53.9%) cases. 
Wound classification may have been inaccurate, but this was addressed during a case by case 
re-evaluation of the data and should not have a significant effect on the analysis, as each 
procedure was carefully considered on its own merit. 
6.1.2. Implications or recommendations 
The awareness and knowledge of SAP guidelines have been shown to be lacking amongst 
anaesthetists at a tertiary hospital in South-Africa.(8) Globally, there is considerable 
variability in SAP compliance, with several studies demonstrating poor 
compliance.(3)(12)(13)(15)(25) Such findings are reproduced in our study, with a non-
compliance rate of 55.6% (p-value < 0.001). The most frequently observed errors included 
incorrect timing of first dose, issues with re-dosing and inconsistencies in prolonged 
continuation of SAP. 
7. Conclusion
Given the devastating consequences of SSI in terms of morbidity and mortality, measures to 
raise awareness and educate clinicians regarding SAP guidelines are warranted. We 
recommend that regular audits of SAP practice should be followed by studies of adherence 
and implementation fidelity. 
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10.Supplementary Files
Supplementary File 1 
*The SIGN recommendations for a minimum data set for SAP audit:(1)
Date and operation performed 
Classification of operation† 
Elective or emergency 
Patient weight 
Previous adverse reactions or allergies to antibiotics 
Justification for prophylaxis; justification for not giving prophylaxis 
Time, name and dosage of antibiotic administrated 
Time of surgical incision 
Duration of surgery 
Whether a second dosage is indicated and/ or given 
Whether postoperative antibiotic prophylaxis is indicated and/ or given 
Whether antibiotic prophylaxis is continued for longer than 24 hours 
Clear documentation 
Supplementary File 2 
†Surgical wound classification (abridged from the ECDC)(23) 
I. Clean surgery: no break in aseptic technique and the respiratory,
gastrointestinal and genitourinary tracts are not breached.
II. Clean-contaminated surgery: this extends to the oropharynx, sterile
genitourinary or biliary tract, the gastrointestinal or respiratory tracts, or if
there has been a minor breech in the aseptic technique.
III. Contaminated surgery: the presence of acute inflammation, infected bilious
secretions, infected urine, or gross contamination from the gastrointestinal
tract.
IV. Dirty surgery: if an established infection exists, and therapeutic antibiotics are
administered based on the susceptibility of bacterial isolates grown from
culture











Age in years, median (IQR) 43 (30-56) 45 (32-60) 44.5 (31.5-
58) 
0.55 










Weight (kg), median (IQR) 76 (61-85) 74 (61-90) 74 (61-90) 0.97 












































































SAP appropriately given, n (%) - 137 (92.0) - - 
31 
SAP appropriately withheld, n (%) 24 (77.4) - - - 
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We are looking to audit current clinical practice/ management of surgical wounds. 
As we will be using data that reflect your clinical practice, we kindly request your consent to 
do so. 
Please note that participation is anonymous and voluntary; and that all information will be 
password protected. This data will not be used evaluate individual performance, but rather 
to obtain a broad view of clinical practice in general. 
For any queries, please contact: 
Dr Delia Schuster: 
- Cell: 0846160382
- Speed dial: 77391
- E-mail: deaschuster@gmail.com
Or 
Dr Owen Porril 
- Cell: 0827840607
- Speed dial: 76788
- E-mail: owen.porrill@uct.ac.za
I hereby grant consent to be included in the study. 
I DO NOT wish to participate in this study. 








Dear Sir/ Madam 
We are looking to audit current clinical practice as pertains to the prevention of wound 
infections during or following surgery. 
This study will not change your management/ treatment in any way; nor will any personal 
information be divulged. All information will be kept anonymous. 
Please be advised that NOT participating in this study WILL NOT affect your treatment 
either. 
Thank you kindly for your time. 
Warmest regards, 
Dr Delia Schuster 
Registrar in Anaesthetics and Peri-operative Medicine 
Groote Schuur Hospital 
deaschuster@gmail.com 
I hereby grant consent to be included in the study. 
I DO NOT wish to participate in this study. 










Please take a moment to complete the following questionnaire on surgical antibiotic 
prophylaxis. 






Weight of patient (please record 
“unknown” if the patient has not been 
weighed) 
Emergency or elective 
(Emergency surgery defined as surgery 
which cannot be delayed for more than six 
hours) 
Elective Emergency 
Surgical wound classification (see 
addendum) 
I  II  III      IV 
Please list any antibiotics administered in 
the 24 hours preceding surgery 
Time of surgical incision 
Duration of surgery 
Thank you for your co-operation! 
Dr Delia Schuster 
MMed research project 
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Department of Anaesthesia and Perioperative Medicine 
Addendum 
I. Clean surgery: no break in aseptic technique and the respiratory,
gastrointestinal and genitourinary tracts are not breached.
II. Clean-contaminated surgery: this extends to the oropharynx, sterile
genitourinary or biliary tract, the gastrointestinal or respiratory tracts, or if
there has been a minor breech in the aseptic technique.
III. Contaminated surgery: the presence of acute inflammation, infected bilious
secretions, infected urine, or gross contamination from the gastrointestinal
tract.
IV. Dirty surgery: if an established infection exists, and therapeutic antibiotics are
administered based on the susceptibility of bacterial isolates grown from
culture
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Prophylactic antibiotic given? Yes No 
 Drug and doses 
Time of antibiotic administration 
2nd Dose administered? Please record time 
and dose, as well as the drug(s) 
Antibiotic prescribed post-operatively? No 24hrs >24hrs
